Skip to content
IPOandMore
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD ReviewNCD Analysis & Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search
Menu Close
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search

IPO Review

  1. Home>
  2. IPO/OFS/Stocks>
  3. IPO Review>
  4. Page 49

CPSE ETF FFO 5 Review

  • Post author:[email protected]
  • Post published:July 17, 2019
  • Post category:IPO Review/Mutual Funds
  • Post comments:0 Comments

CPSE ETF Further Fund offer 5 or the 6th tranche plans to raise about Rs. 12000 crore including the green shoe option. Through the earlier five tranches of the CPSE…

Continue ReadingCPSE ETF FFO 5 Review

CPSE ETF FFO 5 Review

  • Post author:[email protected]
  • Post published:July 17, 2019
  • Post category:IPO Review/Mutual Funds
  • Post comments:0 Comments

CPSE ETF Further Fund offer 5 or the 6th tranche plans to raise about Rs. 12000 crore including the green shoe option. Through the earlier five tranches of the CPSE…

Continue ReadingCPSE ETF FFO 5 Review

Indiamart IPO Review

  • Post author:[email protected]
  • Post published:June 25, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

IndiaMart InterMesh, an online marketplace for business products and services, is coming with its initial public offering. Indiamart IPO opens from June 24 in the price band of Rs 970-973…

Continue ReadingIndiamart IPO Review

Neogen Chemicals IPO: Brokerage Views & Run up to IPO

  • Post author:[email protected]
  • Post published:April 23, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

Continue ReadingNeogen Chemicals IPO: Brokerage Views & Run up to IPO

Neogen Chemicals IPO: Brokerage Views & Run up to IPO

  • Post author:[email protected]
  • Post published:April 23, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

Continue ReadingNeogen Chemicals IPO: Brokerage Views & Run up to IPO

Neogen Chemicals IPO Review

  • Post author:[email protected]
  • Post published:April 23, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

Neogen Chemicals IPO is looking to raise Rs 70 crore by issuing fresh equity shares and also comprises of secondary share sale worth Rs 69 crore by the promoter group.…

Continue ReadingNeogen Chemicals IPO Review

Polycab IPO: Brokerage Views & Run up to IPO

  • Post author:[email protected]
  • Post published:April 5, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Polycab IPO tries to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from various…

Continue ReadingPolycab IPO: Brokerage Views & Run up to IPO

Polycab IPO: Brokerage Views & Run up to IPO

  • Post author:[email protected]
  • Post published:April 5, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Polycab IPO tries to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from various…

Continue ReadingPolycab IPO: Brokerage Views & Run up to IPO

Metropolis Healthcare IPO: Brokerage Views & Run Up to IPO

  • Post author:[email protected]
  • Post published:April 3, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Metropolis Healthcare IPO tries to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from…

Continue ReadingMetropolis Healthcare IPO: Brokerage Views & Run Up to IPO

Metropolis Healthcare IPO: Brokerage Views & Run Up to IPO

  • Post author:[email protected]
  • Post published:April 3, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Metropolis Healthcare IPO tries to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from…

Continue ReadingMetropolis Healthcare IPO: Brokerage Views & Run Up to IPO

Metropolis Healthcare IPO Review

  • Post author:[email protected]
  • Post published:April 1, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

Metropolis Healthcare IPO comprises offer for sale of 13.7 million equity shares, with a face value of ₹2 per share in a price band of Rs. 877-880. Metropolis Healthcare IPO…

Continue ReadingMetropolis Healthcare IPO Review

Metropolis Healthcare IPO Review

  • Post author:[email protected]
  • Post published:April 1, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

Metropolis Healthcare IPO comprises offer for sale of 13.7 million equity shares, with a face value of ₹2 per share in a price band of Rs. 877-880. Metropolis Healthcare IPO…

Continue ReadingMetropolis Healthcare IPO Review
  • Go to the previous page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 76
  • Go to the next page

Archives

Categories

Copyright - WordPress Theme by OceanWP